1 – 10 of 106
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Decoding immune heterogeneity in bladder cancer : From cellular cartography to ex vivo models and antibody-based targeting
2025)(
- Thesis › Doctoral thesis (compilation)
-
Mark
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma : Summary of the 2025 Update
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
A Story of Combining Immunotherapy with Ultra-Hypo-Fractionated Radiation Therapy.
(
- Contribution to journal › Scientific review
- 2024
-
Mark
Revival of recombinant IL-2 therapy–approaches from the past until today
(
- Contribution to journal › Scientific review
-
Mark
Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia
(
- Contribution to journal › Article
-
Mark
Targeting the stressed tumor niche of glioblastoma: Tumor microenvironment and surface antigens
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Effectiveness and infectious complications of BCMA T-cell engagers in treating multiple myeloma : Real-world evidence from Sweden
(
- Contribution to journal › Article
-
Mark
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes
(
- Contribution to journal › Article